Clinical Trial Update: A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies [Phase 3]

View source ↗

Summary

A Phase 3 bioequivalence study comparing Permethrin Cream 5% to Elimite in treating scabies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scabies

Drugs mentioned

• ELIMITE (PERMETHRIN)
• Permethrin Cream, 5% (permethrin)

Snippet

Sponsor: Saptalis Pharmaceuticals LLC | Conditions: Scabies | Phase 3 | Status: COMPLETED